Improvement of the wettability and dissolution of fenofibrate compacts by plasma treatment

International Journal of Pharmaceutics

Volumn 416, Issue 1, 2011, Pages 49-54

  Buch, Philipp ^a   Meyer, Carolin ^a   Langguth, Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Bioavailability; Contact angle; Solubility; Stability; Surface chemistry

Indexed keywords

BUDESONIDE; FENOFIBRATE; FUROSEMIDE; QUERCETIN; TROSPIUM CHLORIDE;

ARTICLE; CONTACT ANGLE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; HYDROPHILICITY; HYDROPHOBICITY; INFRARED SPECTROSCOPY; IRRADIATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAMAN SPECTROMETRY; TABLET COMPRESSION; TABLET SURFACE; WETTABILITY;

DRUG COMPOUNDING; FENOFIBRATE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; OXYGEN; RADIATION, NONIONIZING; SOLUBILITY; TABLETS; WETTABILITY;

EID: 80051793781     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.05.074     Document Type: Article

References (22)

1. S. Brown, G. Rowley, and J.T. Pearson Surface treatment of the hydrophobic drug danazol to improve drug dissolution Int. J. Pharm. 165 1998 227 237 (Pubitemid 28239709)
2. P. Buch, P. Holm, J.Q. Thomassen, D. Scherer, R. Branscheid, U. Kolb, and P. Langguth IVIVC for fenofibrate immediate release tablets using solubility and permeability as in vitro predictors for pharmacokinetics J. Pharm. Sci. 99 2010 4427 4436
3. G. Camenisch, J. Alsenz, H. van de Waterbeemd, and G. Folkers Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight Eur. J. Pharm. Sci. 6 1998 313 319 (Pubitemid 28468539)
4. L. Carrino, G. Moroni, and W. Polini Cold plasma treatment of polypropylene surface: a study on wettability and adhesion Mater. Process. Technol. 121 2002 373 382 (Pubitemid 34201283)
5. R. Casagrande, S.R. Georgetti, and W.A. Verri In vitro evaluation of quercetin cutaneous absorption from topical formulations and its functional stability by antioxidant activity Int. J. Pharm. 328 2007 183 190 (Pubitemid 44895485)
6. P. Chen, C. Zhang, X. Zhang, B. Wang, W. Li, and Q. Lei Effects of oxygen plasma treatment power on surface properties of poly (p-phenylene benzobisoxazole) fibers Appl. Surf. Sci. 255 2008 3153 3158
7. F. Clouet, and M.K. Shi Interactions of polymer model surfaces with cold plasmas: hexatriacontane as a model molecule of high density polyethylene and octadecyl octadecanoate as a model of polyester. I. Degradation rate versus time and power J. Appl. Polym. Sci. 46 1992 1955 1966
8. E.P. Everaert, H.C. Van Der Mei, J. De Vries, and H.J. Busscher Hydrophobic recovery of repeatedly plasma-treated silicone rubber. Part 1. Storage in air J. Adhes. Sci. Technol. 9 1995 1263 1278
9. J.P. Guichard, P. Blouquin, and Y. Qing A new formulation of fenofibrate: suprabioavailable tablets Curr. Med. Res. Opin. 16 2000 134 138 (Pubitemid 30426776)
10. M. Kuzuya, Y. Sasai, Y. Yamauchi, and S. Kondo Pharmaceutical and biomedical engineering by plasma techniques J. Photopolym. Sci. Technol. 21 2008 785 798
11. H. Lin, J.W. Yoo, H.J. Roh, M.K. Lee, S.J. Chung, C.K. Shim, and D.D. Kim Transport of anti-allergic drugs across the passage cultured human nasal epithelial cell monolayer Eur. J. Pharm. Sci. 26 2005 203 210 (Pubitemid 41169803)
12. B.C. Lippold, and A. Ohm Correlation between wettability and dissolution rate of pharmaceutical powders Int. J. Pharm. 28 1986 67 74 (Pubitemid 16210129)
13. A. Munoz, J.P. Guichard, and P.H. Reginault Micronised fenofibrate Atherosclerosis 110 1994 S45 S48
14. A. Naseem, C.J. Olliff, L.G. Martini, and A.W. Lloyd Effects of oxygen plasma treatment on the surface wettability and dissolution of furosemide compacts J. Pharm. Pharmacol. 55 2003 1473 1478 (Pubitemid 37441352)
15. A. Naseem, C.J. Olliff, L.G. Martini, and A.W. Lloyd Effects of plasma irradiation on the wettability and dissolution of compacts of griseofulvin Int. J. Pharm. 269 2004 443 450 (Pubitemid 38045307)
16. M.T. Sheu, C. Yeh, and T.D. Sokoloski Characterization and dissolution of fenofibrate solid dispersion systems Int. J. Pharm. 103 1994 137 146 (Pubitemid 24037045)
17. P. Srinarong, J.H. Faber, M.R. Visser, W.L.J. Hinrichs, and H.W. Frijlink Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants Eur. J. Pharm. Biopharm. 73 2009 154 161
18. F. Tian, N. Sandler, J. Aaltonen, C. Lang, D.J. Saville, K.C. Gordon, C.J. Strachan, J. Rantanen, and T. Rades Influence of polymorphic form, morphology, and excipient interactions on the dissolution of carbamazepine compacts J. Pharm. Sci. 96 2007 584 594 (Pubitemid 46466080)
19. M. Vogt, K. Kunath, and J.B. Dressman Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations Eur. J. Pharm. Biopharm. 68 2008 283 288
20. S.C. Wang, K.S. Chang, and C.J. Yuan Enhancement of electrochemical properties of screen-printed carbon electrodes by oxygen plasma treatment Electrochim. Acta 54 2009 4937 4943
21. Wang, T.; 2007. Effect of surface conditions on DNA detection sensitivity by silicon based bio-sensing devices. Master Thesis.
22. A. Wiedemann, and P.A. Schwantes Antimuscarinic drugs for the treatment of overactive bladder: are they really all the same? - A comparative review of data pertaining to pharmacological and physiological aspects Eur. J. Ger. 9 2007 29 42